Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury

IntroductionTraumatic brain injury (TBI) is a leading cause of disability in the US. Angiotensin 1-7 (Ang-1-7), an endogenous peptide, acts at the G protein coupled MAS1 receptors (MASR) to inhibit inflammatory mediators and decrease reactive oxygen species within the CNS. Few studies have identifie...

Full description

Bibliographic Details
Main Authors: Ryan P. Bruhns, Maha Ibrahim Sulaiman, Michael Gaub, Esther H. Bae, Rachel B. Davidson Knapp, Anna R. Larson, Angela Smith, Deziree L. Coleman, William D. Staatz, Alexander J. Sandweiss, Bellal Joseph, Meredith Hay, Tally M. Largent-Milnes, Todd W. Vanderah
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnbeh.2022.903980/full
_version_ 1811221474525052928
author Ryan P. Bruhns
Maha Ibrahim Sulaiman
Michael Gaub
Esther H. Bae
Rachel B. Davidson Knapp
Anna R. Larson
Angela Smith
Deziree L. Coleman
William D. Staatz
Alexander J. Sandweiss
Bellal Joseph
Meredith Hay
Tally M. Largent-Milnes
Todd W. Vanderah
author_facet Ryan P. Bruhns
Maha Ibrahim Sulaiman
Michael Gaub
Esther H. Bae
Rachel B. Davidson Knapp
Anna R. Larson
Angela Smith
Deziree L. Coleman
William D. Staatz
Alexander J. Sandweiss
Bellal Joseph
Meredith Hay
Tally M. Largent-Milnes
Todd W. Vanderah
author_sort Ryan P. Bruhns
collection DOAJ
description IntroductionTraumatic brain injury (TBI) is a leading cause of disability in the US. Angiotensin 1-7 (Ang-1-7), an endogenous peptide, acts at the G protein coupled MAS1 receptors (MASR) to inhibit inflammatory mediators and decrease reactive oxygen species within the CNS. Few studies have identified whether Ang-(1-7) decreases cognitive impairment following closed TBI. This study examined the therapeutic effect of Ang-(1-7) on secondary injury observed in a murine model of mild TBI (mTBI) in a closed skull, single injury model.Materials and methodsMale mice (n = 108) underwent a closed skull, controlled cortical impact injury. Two hours after injury, mice were administered either Ang-(1-7) (n = 12) or vehicle (n = 12), continuing through day 5 post-TBI, and tested for cognitive impairment on days 1–5 and 18. pTau, Tau, GFAP, and serum cytokines were measured at multiple time points. Animals were observed daily for cognition and motor coordination via novel object recognition. Brain sections were stained and evaluated for neuronal injury.ResultsAdministration of Ang-(1-7) daily for 5 days post-mTBI significantly increased cognitive function as compared to saline control-treated animals. Cortical and hippocampal structures showed less damage in the presence of Ang-(1-7), while Ang-(1-7) administration significantly changed the expression of pTau and GFAP in cortical and hippocampal regions as compared to control.DiscussionThese are among the first studies to demonstrate that sustained administration of Ang-(1-7) following a closed-skull, single impact mTBI significantly improves neurologic outcomes, potentially offering a novel therapeutic modality for the prevention of long-term CNS impairment following such injuries.
first_indexed 2024-04-12T07:59:54Z
format Article
id doaj.art-8d2363e03db44e41afd84e454813225b
institution Directory Open Access Journal
issn 1662-5153
language English
last_indexed 2024-04-12T07:59:54Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Behavioral Neuroscience
spelling doaj.art-8d2363e03db44e41afd84e454813225b2022-12-22T03:41:20ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532022-08-011610.3389/fnbeh.2022.903980903980Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injuryRyan P. Bruhns0Maha Ibrahim Sulaiman1Michael Gaub2Esther H. Bae3Rachel B. Davidson Knapp4Anna R. Larson5Angela Smith6Deziree L. Coleman7William D. Staatz8Alexander J. Sandweiss9Bellal Joseph10Meredith Hay11Tally M. Largent-Milnes12Todd W. Vanderah13Department of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Surgery, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Physiology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesDepartment of Pharmacology, College of Medicine and Health Sciences, University of Arizona, Tucson, AZ, United StatesIntroductionTraumatic brain injury (TBI) is a leading cause of disability in the US. Angiotensin 1-7 (Ang-1-7), an endogenous peptide, acts at the G protein coupled MAS1 receptors (MASR) to inhibit inflammatory mediators and decrease reactive oxygen species within the CNS. Few studies have identified whether Ang-(1-7) decreases cognitive impairment following closed TBI. This study examined the therapeutic effect of Ang-(1-7) on secondary injury observed in a murine model of mild TBI (mTBI) in a closed skull, single injury model.Materials and methodsMale mice (n = 108) underwent a closed skull, controlled cortical impact injury. Two hours after injury, mice were administered either Ang-(1-7) (n = 12) or vehicle (n = 12), continuing through day 5 post-TBI, and tested for cognitive impairment on days 1–5 and 18. pTau, Tau, GFAP, and serum cytokines were measured at multiple time points. Animals were observed daily for cognition and motor coordination via novel object recognition. Brain sections were stained and evaluated for neuronal injury.ResultsAdministration of Ang-(1-7) daily for 5 days post-mTBI significantly increased cognitive function as compared to saline control-treated animals. Cortical and hippocampal structures showed less damage in the presence of Ang-(1-7), while Ang-(1-7) administration significantly changed the expression of pTau and GFAP in cortical and hippocampal regions as compared to control.DiscussionThese are among the first studies to demonstrate that sustained administration of Ang-(1-7) following a closed-skull, single impact mTBI significantly improves neurologic outcomes, potentially offering a novel therapeutic modality for the prevention of long-term CNS impairment following such injuries.https://www.frontiersin.org/articles/10.3389/fnbeh.2022.903980/fulltraumatic brain injuryangiotensin 1-7Mas receptorcognitive impairmentpTau
spellingShingle Ryan P. Bruhns
Maha Ibrahim Sulaiman
Michael Gaub
Esther H. Bae
Rachel B. Davidson Knapp
Anna R. Larson
Angela Smith
Deziree L. Coleman
William D. Staatz
Alexander J. Sandweiss
Bellal Joseph
Meredith Hay
Tally M. Largent-Milnes
Todd W. Vanderah
Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
Frontiers in Behavioral Neuroscience
traumatic brain injury
angiotensin 1-7
Mas receptor
cognitive impairment
pTau
title Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
title_full Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
title_fullStr Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
title_full_unstemmed Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
title_short Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
title_sort angiotensin 1 7 improves cognitive function and reduces inflammation in mice following mild traumatic brain injury
topic traumatic brain injury
angiotensin 1-7
Mas receptor
cognitive impairment
pTau
url https://www.frontiersin.org/articles/10.3389/fnbeh.2022.903980/full
work_keys_str_mv AT ryanpbruhns angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT mahaibrahimsulaiman angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT michaelgaub angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT estherhbae angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT rachelbdavidsonknapp angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT annarlarson angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT angelasmith angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT dezireelcoleman angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT williamdstaatz angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT alexanderjsandweiss angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT bellaljoseph angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT meredithhay angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT tallymlargentmilnes angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury
AT toddwvanderah angiotensin17improvescognitivefunctionandreducesinflammationinmicefollowingmildtraumaticbraininjury